Discovery and functional characterization of enhancer hijacking oncogene rearrangements in NSCLC using Hi-C sequencing of FFPE tumors
Sikkink, et al.
AACR 2026 - San Diego, CA
Detection and functional assessment of extrachromosomal DNA amplifications in FFPE lung tumor specimens using Hi-C sequencing
Sikkink, et al.
AACR 2026 - San Diego, CA
Hi-C FFPE sequencing analysis is highly concordant with FISH and detects additional variants informing diagnosis and treatment in diffuse large B-cell lymphoma
Xu-Monette, et al.
ASH 2025 - Orlando, FL
Application of Hi-c sequencing to detect cryptic and novel structural aberrations in lymphoid neoplasms
Rozenova, et al.
ASH 2025 - Orlando, FL
Cytogenetic Advances in NHL Diagnosis by Leveraging Hi-C Sequencing
Sikkink, et al.
AMP 2025 - Boston, MA
Hi-C FFPE Sequencing for Detection of Fusions and Rearrangements that are Diagnostic, Prognostic, and Therapeutic Biomarkers in Lymphoma
Hastie, et al.
Lymphoma, Leukemia & Myeloma Congress 2025 - New York, New York
Molecular Analysis of Driver Negative Lung Cancer for Rearrangements and Fusions Using a New HiC Sequencing Assay
Ricketts, et al.
2025 World Conference on Lung Cancer - Barcelona, Spain
Aventa Lymphoma based on Hi-C FFPE Sequencing is an Alternative to FISH and Detects Additional Variants Informing Diagnosis and Therapy in Lymphomas
Hastie, et al.
16th Annual Meeting of the Cancer Genomics Consortium - Houston, TX
Aventa FusionPlus based on Hi-C FFPE Sequencing Detects Fusions Genome-Wide with High Sensitivity in Solid Tumors
Hastie, et al.
16th Annual Meeting of the Cancer Genomics Consortium - Houston, TX